Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_assertion description "[PELP1 (proline, glutamic acid and leucine rich protein 1) is a nuclear receptor coregulator that is upregulated during breast cancer progression to metastasis and is an independent prognostic predictor of shorter survival of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_assertion evidence source_evidence_literature NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_assertion SIO_000772 23975430 NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_assertion wasDerivedFrom befree-20150227 NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_assertion wasGeneratedBy ECO_0000203 NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP885170.RAfAYWpxD1FSRv0vxsmqtbWhl6Qtd2iOMH9i1DIjMUIpI130_provenance.